Andreas Hougaard Laustsen

Andreas Hougaard Laustsen

Associate professor | Co-founder of Biosyntia, Antag Therapeutics, Bactolife, VenomAb, Chromologics, REBBLS.

Andreas is specialized in antibody discovery, toxinology, and snakebite antivenom. He holds a PhD from the University of Copenhagen, and a M.Sc. Eng. from the Technical University of Denmark. He is co-founder of the companies Biosyntia, VenomAb, Antag Therapeutics, Chromologics, and Bactolife. Furthermore, Andreas is recognized as Denmark’s Coolest Engineer, Top 10 Biotech Entrepreneur under 30 in Europe 2016, Top 6 Entrepreneurial Academic under 35 in Europe 2017, 30 under 30 by Forbes 2017, and a Top 35 Innovator under 35 by MIT Technology Review 2017. Recently, he has been appointed as an advisor at the WHO Snakebite Envenoming Group.

Aneesh Karatt Vellatt

Aneesh Karatt Vellatt

Group Leader/Project Manager at IONTAS (Antibodies)

Dr. Aneesh Karatt-Vellatt is a Group leader at Iontas Ltd, an antibody drug discovery company based in Cambridge, UK. Aneesh joined Iontas after completing a PhD in Biochemistry from the University of Cambridge. At Iontas, a team lead by Dr. Karatt-Vellatt developed a novel platform technology that facilitates antibody generation against traditionally difficult therapeutic targets such as ion channels and GPCR’s. He is also a key member of an international scientific consortium that aims to develop recombinant antivenoms based on human IgG monoclonal antibodies to treat snakebites.

 

... more coming soon!